Research breakthrough could halt melanoma metastasis

In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 (mda-9)/syntenin. More than 1 million cases of skin cancer are diagnosed each year in the U.S., and melanoma is the deadliest form. With further research, the approach used by the scientists could lead to targeted therapies that stop metastasis in melanoma and potentially a broad range of additional cancers.

Read more

Green tea found to reduce rate of some GI cancers

Women who drink green tea may lower their risk of developing some digestive system cancers, especially cancers of the stomach/esophagus and colorectum, according to a study led by researchers from Vanderbilt-Ingram Cancer Center.

Read more

Scientists harness immune system to prevent lymphoma relapse

UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body’s own immune system, after highly promising early laboratory results.

Read more

U of M researchers develop new drug to target and destroy tumor cells

A new drug created at the University of Minnesota may hold the answer to defeating pancreatic cancer, according to results published today in the prestigious journal Science Translational Medicine.

Read more

Cold viruses point the way to new cancer therapies

 

Cold viruses generally get a bad rap—-which they’ve certainly earned—-but new findings by a team of scientists at the Salk Institute for Biological Studies suggest that these viruses might also be a valuable ally in the fight against cancer.

Read more

RNA-based therapy brings new hope for an incurable blood cancer

 

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

Read more

Scientists develop ‘barcode’ blood test for aggressive prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode ? and can pick out aggressive prostate cancers by their particular pattern of gene activity.

A team at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust found reading the pattern of genes switched on and off in blood cells could accurately detect which advanced prostate cancers had the worst survival.

Read more

Phase III data in treatment of renal cell carcinoma reported

 

New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Read more

Should aspirin be used to prevent cancer?

Aspirin, the everyday drug taken by countless people around the world to ward off pain and reduce their risk of developing heart disease, may have a new trick up its sleeve ?-preventing cancer.

A growing body of evidence suggests that taking aspirin may reduce an individual’s chances of developing colorectal cancer and perhaps other malignancies, but whether that evidence is strong enough to outweigh the risks of prescribing it to millions of healthy people is the subject of debate.

Read more

New hope for taming triple-negative breast cancer

 

Disease-free survival is short-lived for women with triple-negative breast cancer ? a form of the disease that doesn’t respond to hormone drugs and becomes resistant to chemotherapy. Thankfully, a promising line of study in the School of Medicine at The University of Texas Health Science Center San Antonio suggests it is possible to fine-tune the properties of this fearsome cancer, making it more sensitive to treatment.

Read more

Next Page »